Search

everythinglearnresearchcommunity

for

Search:↓

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

The COVID-19 pandemic changed the types of skin conditions seen at a clinic, with fewer patients and varying numbers of specific conditions.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.

Convolvulus arvensis ethanolic extract can potentially promote hair growth and reduce hair loss.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Thai rice bran extracts, especially from Tubtim Chumphae rice, can significantly reduce the activity of hair loss genes, with x-tocopherol showing potential as an anti-hair loss product.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

More people are searching for hair transplants online, preferring Follicular Unit Excision over Follicular Unit Transplant. There's also a rise in female patients and interest in beard, eyebrow transplants, and non-surgical treatments like platelet rich plasma.

H-1 antihistamines may help with various skin conditions, but more research is needed to confirm their effectiveness.

Dermatologists helped identify COVID-19 through skin symptoms and managed skin issues during the pandemic, but more high-quality research is needed.

Certain Dibenzo derivatives may help treat prostate cancer.

More children are showing signs of hair-pulling disorders during the COVID-19 pandemic due to stress and lack of social interaction.

Hair loss doesn't affect COVID-19 severity.

MSC-Exos can aid organ development and offer therapeutic benefits for various conditions.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

University students in Egypt experienced high stress during COVID-19's third wave, with negative coping mechanisms being more common.

Topical spironolactone may help treat ocular graft-versus-host disease with minimal side effects.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Epipharyngeal Abrasive Therapy helps reduce symptoms in Long COVID patients with chronic epipharyngitis.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.